secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0000950170-23-023014
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulgent Genetics stockholders approve 3M share increase to 2016 Incentive Plan
------------------------------------------------------------------------------

- Stockholders elected all four director nominees: Ming Hsieh, Michael Nohaile, Regina Groves, Linda Marsh.
- Ratified Deloitte & Touche LLP as independent auditor for fiscal year 2023.
- Advisory vote approved executive compensation with 18.9M for and 0.6M against.
- Amended 2016 Omnibus Plan approved to increase shares reserved by 3M (10.8M for, 8.7M against).
- Plan amendment adds 3M shares, representing ~10% dilution relative to 29.7M shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000095017023023014/0000950170-23-023014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000095017023023014/flgt-20230518.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-023014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer